PMID- 17346934 OWN - NLM STAT- MEDLINE DCOM- 20070613 LR - 20121115 IS - 0923-1811 (Print) IS - 0923-1811 (Linking) VI - 46 IP - 2 DP - 2007 May TI - Increase of collagen synthesis by obovatol through stimulation of the TGF-beta signaling and inhibition of matrix metalloproteinase in UVB-irradiated human fibroblast. PG - 127-37 AB - BACKGROUND: Alterations of the extracellular matrix (ECM) is critical in the photo and age-damaged skin. Thus any compounds keep ECM can protected from photo and aged-damaged skin. ECM is predominantly composed of type I and type III collagens in the dermis. Transforming growth factor (TGF-beta)s play important roles in cellular biosynthesis of extracellular matrix. Activator protein 1 (AP-1) and Smad are significant factors that mediate TGF-beta. OBJECTIVE: We have investigated increasing effects of obovatol, a biphenolic compound isolated from leaves of Magnolia obovata on the collagen synthesis through stimulation of the TGF-beta signaling and inhibition of matrix metalloproteinase, thereby protect against from UV damages via maintain of collagen in the UVB irradiated human fibroblast cells. METHODS: The fibroblasts were pretreated with obovatol for 24h and then the cells were irradiated with UVB. UVB-exposed cells were further cultured for 24h. Type I procollagen, MMP-3, TGF-beta and Smad as well as phosphorylation of MAPK family expression were determined by Western blot. The activation of AP-1 was investigated using EMSA. The released type I procollagen and TGF-beta into cell culture medium were determined by Western blot after concentration of these proteins. RESULTS: The results showed that obovatol stimulated type I procollagen, TGF-beta, and Smad expression and inhibited matrix metalloproteinase-3 (MMP-3) in dose-dependent manner (1-5muM) in UVB-irradiated human fibroblast cells. Obovatol also inhibited UVB-induced activation of AP-1 and MAP kinases. CONCLUSION: These results suggest that obovatol increases collagen synthesis through stimulation of the TGF-beta signaling and inhibition of matrix metalloproteinase in UVB-irradiated human fibroblast, thus obovatol could be effective against photo-damaged skin. FAU - Choi, Myoung Suk AU - Choi MS AD - College of Pharmacy, Chungbuk National University, 48, Gaesin-dong, Heungduk-gu, Cheungju, Chungbuk 361-763, South Korea. FAU - Yoo, Myung Sik AU - Yoo MS FAU - Son, Dong Ju AU - Son DJ FAU - Jung, Hai Young AU - Jung HY FAU - Lee, Seung Ho AU - Lee SH FAU - Jung, Jae Kyung AU - Jung JK FAU - Lee, Beom Cheon AU - Lee BC FAU - Yun, Yeo Pyo AU - Yun YP FAU - Pyo, Hyeong Bae AU - Pyo HB FAU - Hong, Jin Tae AU - Hong JT LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070307 PL - Netherlands TA - J Dermatol Sci JT - Journal of dermatological science JID - 9011485 RN - 0 (Biphenyl Compounds) RN - 0 (Collagen Type I) RN - 0 (Matrix Metalloproteinase Inhibitors) RN - 0 (Phenyl Ethers) RN - 0 (Radiation-Protective Agents) RN - 0 (Smad Proteins) RN - 0 (Transcription Factor AP-1) RN - 0 (Transforming Growth Factor beta) RN - 83864-78-2 (obovatol) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM MH - Biphenyl Compounds/isolation & purification/*pharmacology MH - Cells, Cultured MH - Collagen Type I/*biosynthesis MH - Dose-Response Relationship, Drug MH - Dose-Response Relationship, Radiation MH - Fibroblasts/*drug effects/metabolism/radiation effects MH - Humans MH - Magnolia/chemistry MH - Matrix Metalloproteinase 3/metabolism MH - *Matrix Metalloproteinase Inhibitors MH - Mitogen-Activated Protein Kinases/metabolism MH - Phenyl Ethers/isolation & purification/*pharmacology MH - Phosphorylation MH - Plant Leaves MH - Radiation-Protective Agents/isolation & purification/*pharmacology MH - Signal Transduction/*drug effects MH - Skin/drug effects/metabolism/radiation effects MH - Smad Proteins/metabolism MH - Transcription Factor AP-1/metabolism MH - Transforming Growth Factor beta/*metabolism MH - *Ultraviolet Rays EDAT- 2007/03/10 09:00 MHDA- 2007/06/15 09:00 CRDT- 2007/03/10 09:00 PHST- 2006/06/23 00:00 [received] PHST- 2006/12/13 00:00 [revised] PHST- 2007/02/01 00:00 [accepted] PHST- 2007/03/10 09:00 [pubmed] PHST- 2007/06/15 09:00 [medline] PHST- 2007/03/10 09:00 [entrez] AID - S0923-1811(07)00054-0 [pii] AID - 10.1016/j.jdermsci.2007.02.001 [doi] PST - ppublish SO - J Dermatol Sci. 2007 May;46(2):127-37. doi: 10.1016/j.jdermsci.2007.02.001. Epub 2007 Mar 7.